Literature DB >> 20939951

[Gallbladder polypoid lesions. Three clinical cases with difficult diagnosis and literature review].

E Spaziani1, V Petrozza, A Di Filippo, M Picchio, F Ceci, A Miraglia, V Moretti, M Briganti, E Greco, G Pattaro, F De Angelis, C Salvadori, F Stagnitti.   

Abstract

INTRODUCTION: Gallbladder polypoid lesions occur in 1.3%-6.9% of cases. The preoperative diagnosis between benign, malignant and potentially malignant lesions is difficult. Therefore it is not possible any. PATIENTS AND METHODS: The Authors describe three cases. The case 1 was a gallbladder diffuse adenomyomatosis; the ultrasound and the CT were of little help in defining preoperatively the nature and the gravity of the thickening. Case 2 was an adenomyomatosis of the fundus: the ultrasound examinations were not able to establish preoperatively lesion's nature, site and dimensions. In the case 3, ultrasounds showed polypoid lesions and calculi concrections not found in colecistectomy. DISCUSSION: The ultrasound is the most widely used diagnostic tool in the evaluation of gallbladder polypoid lesions; its accuracy is only 66%. CT, which has an accuracy level of 75%, must be carried out there is any possibility of malignant degeneration of the polyp. If doubts persist, a MR, 93% accuracy, is indicated. In selected cases, PET can be of further help.
CONCLUSIONS: The preoperative diagnosis of the nature of gallbladder polypoid lesions is "difficult" and this justifies the lack of consensus on treatment. However, the adenoma-carcinoma sequence, widely discussed in literature, can justifies to the use of CT, MR, PET and surgical treatment after an ultrasound examination.

Entities:  

Mesh:

Year:  2010        PMID: 20939951

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  1 in total

1.  Analysis of risk factors for polypoid lesions of gallbladder among health examinees.

Authors:  Hua-Li Yang; Lei Kong; Li-Li Hou; Hui-Fang Shen; Yu Wang; Xin-Gang Gu; Jian-Min Qin; Pei-Hao Yin; Qi Li
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.